Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR ‐mutant non‐small cell lung cancer

BACKGROUND: Evidence on the influence of programmed death‐ligand 1 (PD‐L1) expression on the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) in EGFR‐mutant non‐small cell lung cancer (NSCLC) patients is at variance. METHODS: A single‐center retrospective study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Si‐Yu, Xu, Hai‐Yan, Li, Hong‐Shuai, Yang, Ya‐Ning, Xu, Fei, Li, Jun‐Ling, Wang, Zhi‐Jie, Xing, Pu‐Yuan, Hao, Xue‐Zhi, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447169/
https://www.ncbi.nlm.nih.gov/pubmed/37407282
http://dx.doi.org/10.1111/1759-7714.15021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447169/
https://www.ncbi.nlm.nih.gov/pubmed/37407282
http://dx.doi.org/10.1111/1759-7714.15021

Ejemplares similares